Integrated Filing — IndAS

General information about company
Scrip Code	541540
NSE Symbol	SOLARA
MSEI Symbol	NOTLISTED
ISIN	INE624Z01016
Name of company	Solara Active Pharma Sciences Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	07-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Active Pharmaceutical Ingredients (API)
Start date and time of board meeting	15-May-2025   12:15:00
End date and time of board meeting	15-May-2025   14:10:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	2730100000	12837600000
	Other income	59500000	83200000
	Total income	2789600000	12920800000
2	Expenses
(a)	Cost of materials consumed	1436700000	5816600000
(b)	Purchases of stock-in-trade	50500000	57500000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-306300000	390000000
(d)	Employee benefit expense	522900000	2116900000
(e)	Finance costs	291200000	1148100000
(f)	Depreciation, depletion and amortisation expense	243000000	992500000
(f)	Other Expenses
1	Other expenses	572600000	2393800000
	Total other expenses	572600000	2393800000
	Total expenses	2810600000	12915400000
3	Total profit before exceptional items and tax	-21000000	5400000
4	Exceptional items	0	0
5	Total profit before tax	-21000000	5400000
6	Tax expense
7	Current tax	0	0
8	Deferred tax	0	0
9	Total tax expenses	0	0
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-21000000	5400000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-21000000	5400000
17	Other comprehensive income net of taxes	-6200000	9800000
18	Total Comprehensive Income for the period	-27200000	15200000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	-21000000	5400000
	Total profit or loss, attributable to non-controlling interests	-10000	-10000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	-6200000	9800000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
21	Details of equity share capital
	Paid-up equity share capital	402500000	402500000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		0
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-0.93	0.14
	Diluted earnings (loss) per share from continuing operations	-0.93	0.14
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-0.93	0.14
	Diluted earnings (loss) per share from continuing and discontinued operations	-0.93	0.14
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	7386800000
	Capital work-in-progress	2800500000
	Investment property	22800000
	Goodwill	3649000000
	Other intangible assets	298000000
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	17000000
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	163200000
	Total non-current financial assets	180200000
	Deferred tax assets (net)
	Other non-current assets	693800000
	Total non-current assets	15031100000
2	Current assets
	Inventories	3179000000
	Current financial asset
	Current investments	0
	Trade receivables, current	3265700000
	Cash and cash equivalents	39500000
	Bank balance other than cash and cash equivalents	1600000
	Loans, current	200000
	Other current financial assets	123600000
	Total current financial assets	3430600000
	Current tax assets (net)
	Other current assets	677700000
	Total current assets	7287300000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	22318400000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	402500000
	Other equity	10539900000
	Total equity attributable to owners of parent	10942400000
	Non controlling interest	26700000
	Total equity	10969100000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1138600000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities	181900000
	Total non-current financial liabilities	1320500000
	Provisions, non-current	98500000
	Deferred tax liabilities (net)
	Deferred government grants, Non-current
	Other non-current liabilities	489200000
	Total non-current liabilities	1908200000
	Current liabilities
	Current financial liabilities
	Borrowings, current	6622000000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	379900000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	2106300000
	Total Trade payable	2486200000
	Other current financial liabilities	201400000
	Total current financial liabilities	9309600000
	Other current liabilities	109100000
	Provisions, current	22300000
	Current tax liabilities (Net)	100000
	Deferred government grants, Current
	Total current liabilities	9441100000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	11349300000
	Total equity and liabilites	22318400000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement gains/(losses) of defined benefit plans	-6400000	10600000
	Total Amount of items that will not be reclassified to profit and loss	-6400000	10600000
2	Income tax relating to items that will not be reclassified to profit or loss	0	0
3	Amount of items that will be reclassified to profit and loss
1	Exchange differences on translating the financial statements of foreign operations	200000	-800000
	Total Amount of items that will be reclassified to profit and loss	200000	-800000
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-6200000	9800000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			5400000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			1148100000
	Adjustments for decrease (increase) in inventories			418000000
	Adjustments for decrease (increase) in trade receivables, current			198100000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-100200000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-594300000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			108600000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			992500000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-14700000
	Adjustments for dividend income			0
	Adjustments for interest income			7600000
	Adjustments for share-based payments			26800000
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-10200000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-33300000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			2131800000
	Net cash flows from (used in) operations			2137200000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			9000000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			2128200000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			9600000
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			399400000
	Proceeds from sales of investment property			3800000
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			7500000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			10200000
	Net cash flows from (used in) investing activities	-368300000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			1590200000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			750000000
	Repayments of borrowings			2963800000
	Payments of lease liabilities			21300000
	Dividends paid			0
	Interest paid			1131000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-28900000
	Net cash flows from (used in) financing activities			-1804800000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-44900000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-44900000
	Cash and cash equivalents cash flow statement at beginning of period			84400000
	Cash and cash equivalents cash flow statement at end of period			39500000